Search Results - "de BAPTISTA, Enma Araujo"

Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain by Baptista, Trino, ElFakih, Yamily, Uzcátegui, Euderruh, Sandia, Ignacio, Tálamo, Eduardo, de Baptista, Enma Araujo, Beaulieu, Serge

“…Excessive bodyweight gain was reported during the 1950s as an adverse effect of typical antipsychotic drug treatment, but the magnitude of bodyweight gain was…”
Get full text

Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study by Carrizo, Edgardo, Fernández, Virginia, Connell, Lisette, Sandia, Ignacio, Prieto, Dexy, Mogollón, Johana, Valbuena, Dennys, Fernández, Iliana, Araujo de Baptista, Enma, Baptista, Trino

“…Abstract Background Clozapine is the most effective agent in treatment-resistant schizophrenia. However, it is frequently associated with excessive body weight…”
Get full text

Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: A multicentric, double-blind, placebo-controlled trial by Baptista, Trino, Rangel, Nairy, Fernández, Virginia, Carrizo, Edgardo, El Fakih, Yamily, Uzcátegui, Euderruh, Galeazzi, Tatiana, Gutiérrez, María A, Servigna, Mercedes, Dávila, Adriana, Uzcátegui, Marycelvia, Serrano, Ana, Connell, Lisette, Beaulieu, Serge, de Baptista, Enma Araujo

“…Abstract Background Excessive body weight gain (BWG) is a clinically relevant side effect of olanzapine administration. The primary objective of this study was…”
Get full text

Polymorphisms of the LEP - and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin by Fernández, Erika, Carrizo, Edgardo, Fernández, Virginia, Connell, Lisette, Sandia, Ignacio, Prieto, Dexy, Mogollón, Johana, Valbuena, Dennys, Fernández, Iliana, de Baptista, Enma Araujo, Baptista, Trino

“…Abstract Background The role of leptin in atypical antipsychotic-induced metabolic dysfunction was explored by assessing the anthropometric and metabolic…”
Get full text

The metabolic syndrome and its constituting variables in atypical antipsychotic-treated subjects: Comparison with other drug treatments, drug-free psychiatric patients, first-degree relatives and the general population in Venezuela by Baptista, Trino, Serrano, Ana, Uzcátegui, Euderruh, ElFakih, Yamily, Rangel, Nairy, Carrizo, Edgardo, Fernández, Virginia, Connell, Lisette, de Baptista, Enma Araujo, Quiroz, Segundo, Uzcátegui, Marycelvia, Rondón, Juana, Matos, Yimber, Uzcátegui, Lilia, Gómez, Roald, Valery, Lenin, Novoa-Montero, Darío

“…Abstract Background Few studies on the association between atypical antipsychotic drug (AAP) administration and metabolic dysfunction have concurrently…”
Get full text

Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: A 12-week double-blind, placebo-controlled pilot study by Baptista, Trino, Uzcátegui, Euderruh, Rangel, Nairy, El Fakih, Yamily, Galeazzi, Tatiana, Beaulieu, Serge, de Baptista, Enma Araujo

“…Abstract Metformin (850-1700 mg) plus sibutramine (10-20 mg, n = 13) or placebo ( n = 15) was administered for 12 weeks in olanzapine-treated chronic…”
Get full text

Frequency of abnormal correlation between leptin and the body mass index during first and second generation antipsychotic drug treatment by Peña, Rocio, Marquina, David, Serrano, Ana, elFakih, Yamily, de Baptista, Enma Araujo, Carrizo, Edgardo, Fernández, Virginia, Valery, Lenin, Teneud, Luis, Baptista, Trino

“…Abstract Background Leptin dysregulation has been implicated in the body weight gain and metabolic dysfunction observed with the second generation…”
Get full text

Corrigendum to “Extended release metfomin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study” [Schizophr. Res. 113 (1) (2009) 19–26] by Carrizo, Edgardo, Fernández, Virginia, Sandia, Ignacio, Prieto, Dexy, Mogollón, Johana, Connel, Lisette, Valbuena, Dennys, Fernández, Iliana, de Baptista, Enma Araujo, Baptista, Trino

Get full text

Tamoxifen Prevents Sulpiride-Induced Weight Gain in Female Rats by Baptista, Trino, de BAPTISTA, Enma Araujo, Hernandez, Luis, Altemus, Marty, Weiss, Susan R

“…To evaluate its potential utility in counteracting neuroleptic-induced obesity, the effects of long-term administration of tamoxifen (TAM) on body weight (BW)…”
Get full text

Effects of lithium carbonate on reproductive hormones in healthy men: Relationship with body weight regulation-a pilot study by Baptista, Trino, Alastre, Tomás, Contreras, Quilianio, Martinez, JoséLuis, De Baptista, Enma Araujo, Burguera, JoséLuis, De Burguera, Marcela, Hernández, Luis

“…1. 1. To test the hypothesis that lithium-induced body weight gain is related to an unbalance in the reproductive hormones, lithium carbonate (900 mg/day) or…”
Get full text